未知生产厂商
Recombinant super-compound interferon (rSIFN-co) is a recombinant version of interferon alpha with modified spatial configuration. This interferon has antiviral and antitumor activity.
Recombinant super-compound interferon (rSIFN-co) is a recombinant version of interferon alpha with modified spatial configuration. This interferon has antiviral and antitumor activity.
RSIFN-co has immunomodulation, antiviral, and antineoplastic activities. It binds to IFN-specific cell surface receptors and causes transcription and translation of genes that have protein products with antiviral, antiproliferative, anticancer, and immunomodulating effects. It is currently being investigated for viral diseases and cancer.
